iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dr Reddys Laboratories Ltd Option Chain

1,237.1
(-0.02%)
Oct 15, 2025|12:19:58 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
--1,040₹0.4 0%63,7500%
--1,080₹0.5 0%1,40,0000%
--1,100₹0.8 -33.33%1,78,7500%
--1,110₹0.5 -74.35%13,1250%
2,5000%₹121.1 0%1,120₹1.1 -43.58%2,16,250107.18%
--1,130₹2.15 0%25,0000%
5,0000%₹124.45 0%1,140₹2.05 -32.78%1,03,7507.79%
--1,150₹2.55 -34.61%71,250-5%
15,0000%₹110.1 0%1,160₹3.45 -32.35%80,0000%
3,7500%₹88.45 0%1,170₹4.85 -15.65%20,625-13.15%
23,125-7.5%₹68.45 -2.42%1,180₹6.15 -21.15%1,10,000-3.82%
12,5000%₹56.45 -3.25%1,190₹7.8 -19.17%50,00012.67%
53,12514.86%₹51.1 -3.49%1,200₹9.95 -18.1%3,32,5003.30%
12,500-4.76%₹43.9 -0.45%1,210₹12.7 -19.1%74,3751.70%
39,375-12.5%₹37.6 -0.26%1,220₹16 -13.74%1,76,875-2.07%
38,75012.72%₹30.6 -2.85%1,230₹19.4 -16.01%76,25011.92%
1,62,5003.58%₹24.75 -4.44%1,240₹24.05 -9.75%3,90,625-2.49%
2,63,12512.56%₹19.55 -7.56%1,250₹28.95 -6%3,50,0008.94%
8,95,00010.57%₹15.5 -8.01%1,260₹34 -7.85%1,40,625-16.35%
2,89,375-2.32%₹11.65 -11.4%1,270₹40.9 -2.85%90,000-3.35%
3,40,0000.55%₹8.8 -12.87%1,280₹47.25 -1.04%88,7500%
2,38,750-1.29%₹6.55 -13.24%1,290₹58 1.48%39,3750%
8,78,1252.70%₹4.75 -15.92%1,300₹62.95 -5.4%1,63,7500%
1,18,7500.52%₹3.5 -17.64%1,310₹72.55 37.01%17,5007.69%
10,24,3750.49%₹2.4 -22.58%1,320₹80.65 -0.73%79,375-3.05%
68,7507.84%₹1.75 -27.08%1,330₹67 0%26,8750%
5,84,375-0.84%₹1.3 -25.71%1,340₹97.55 0%37,5000%
81,8753.96%₹1.2 -11.11%1,350--
1,91,8750.98%₹0.85 -19.04%1,360₹106.5 0%27,5000%
8,1250%₹1.45 -3.33%1,370--
1,00,0000%₹0.75 0%1,380₹130 0%18,7500%
5,20,625-1.76%₹0.35 -46.15%1,400₹129.9 0%14,3750%
2,37,5000%₹0.4 33.33%1,420--
30,0000%₹0.3 0%1,440--
--1,480₹238 0%6250%
5,0000%₹0.05 0%1,520--

Dr Reddys Labs: Related NEWS

US FDA Issues Form 483 With Five Observations at Dr Reddy’s Biologics Facility

The inspection, conducted between September 4 and September 12, 2025, was a pre-approval review.

15 Sep 2025|11:10 AM
Read More
Top Stocks for Today - 15th September 2025

Here are some of the stocks that may see significant price movement today: Apollo Hospitals, GMR Airports, RailTel Corporation, etc.

15 Sep 2025|07:44 AM
Read More
Dr Reddy’s Infuses ₹565 Cr into Russian Arm

The capital was infused via cash and will be used to support DRL Russia’s working capital requirements.

28 Jul 2025|12:22 PM
Read More
Dr Reddy’s Laboratories inks pact with Alvotech; stock gains ~3%

As per the terms agreement, Alvotech and Dr Reddy’s will jointly develop and manufacture the biosimilar candidate and share costs and responsibilities.

5 Jun 2025|11:00 AM
Read More
Dr. Reddy’s Receives Two USFDA Observations for New York API Manufacturing Plant

Issuance of a Form 483 occurs when an investigator(s) has observed any conditions that in their judgment may constitute violations of the FD&C Act and related Acts.

18 May 2025|07:17 PM
Read More
Dr Reddy’s Q4 Profit Jumps 22% to ₹1,594 Crore

The board has recommended a final dividend of ₹8 per equity share for FY 2024–25

12 May 2025|01:00 PM
Read More
Top Stocks for Today - 12th May 2025

Here are some of the stocks that may see significant price movement today: Adani Power, Dr Reddy's, and Bank of India, etc.

12 May 2025|09:32 AM
Read More
Dr. Reddy’s Laboratories Sells 14 ANDAs to Senores Pharma

Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.

5 Mar 2025|11:05 AM
Read More
Top Stocks for - 27th February 2025

Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.

26 Feb 2025|09:22 PM
Read More
Dr Reddy’s Hyderabad API Unit Gets USFDA VAI Classification

Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore. 

25 Feb 2025|08:42 PM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.